Cell Cure Neurosciences Ltd. announced that it will receive $5,000,000 in funding from existing investor, Hadasit Bio-Holdings, Ltd. on March 31, 2016. The company will issue convertible loan in the transaction.
HBL - Hadasit Bio-Holdings Ltd TEL AVIV STOCK EXCHANGE
Equities
HDST
IL0010954050
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |